Recognizing demands precisely and expanding business globally

female-medical-or-scientific-researcher-

PHARMACEUTICALCOMPANY

GUPHARG DMCC is registered in Dubai, UAE.

We provide a complete solution for our client’s needs by offering high quality pharmaceutical products, medical equipment, medical devices. We offer safe, high-quality products and services, while taking responsibility for a fair and sustainable chain.
We are determined to build on long-standing, trusted relationships with our clients.
GUPHARG DMCC provides and assistant in creating a strategy for your market access and help you to identify the countries for sales. We offer excellent marketing services and adjust your strategic marketing plan to fit markets so you can receive the most beneficial outcomes

WELCOME TO
GUPHARG DMCC.

About

MISSION

Our mission is to provide our customers with world-class pharmaceutical and medical products.

the-coronavirus-or-covid-vaccine-researched-by-pha-2021-12-09-22-08-35-utc.jpg

Mission

group-of-doctors-in-modern-clinic-2022-07-27-21-48-55-utc.jpg

PHARMACEUTICAL PRODUCTS

GUPHARG DMCC handles import / export and distribution of different types of pharmaceutical and nutraceutical products. Our experience and a solid network of contacts allow us to provide a wide range of high quality pharmaceutical products to international companies.

Products

GUPHARG DMCC is a provider and expert in medical supplies and equipment for patients and health professionals. Manufacturers are carefully selected to share the same view on quality.

MEDICAL EQUIPMENT

GUPHARG DMCC is a provider and expert in medical supplies and equipment for patients and health professionals. Manufacturers are carefully selected to share the same view on quality.

Equipment

MEDICAL DEVICES

GUPHARG DMCC provides high quality medical devices for various fields, including devices for plastic surgery and aesthetics.
The global medical aesthetic devices was valued at USD 13,708.42 million in 2021 and is expected to reach USD 26812.32 million in 2027, registering a CAGR of 11.83% during the forecast period (2022-2027).